Icon

TOPOTECAN (nda200199)- (EQ 1MG BASE/ML (EQ 1MG BASE/ML),EQ 3MG BASE/3ML (EQ 1MG BASE/ML),EQ 4MG BASE/4ML (EQ 1MG BASE/ML))

TOPOTECAN HYDROCHLORIDE SANDOZ INC
EQ 1MG BASE/ML (EQ 1MG BASE/ML),EQ 3MG BASE/3ML (EQ 1MG BASE/ML),EQ 4MG BASE/4ML (EQ 1MG BASE/ML)
No Yes
Expired Expired
None None
None No
Topotecan is a topoisomerase inhibitor indicated for:  small cell lung cancer sensitive disease after failure of first-line chemotherapy.  combination therapy with cisplatin for stage IV-B, recurrent, or persistent carcinoma of the cervix which is not amenable to curative treatment with surgery and/or radiation therapy.
0 0 0
Total Other Developers 1
Drugs with Suitability No
EQ 1MG BASE/ML (EQ 1MG BASE/ML) ** ** - - -
EQ 3MG BASE/3ML (EQ 1MG BASE/ML) ** ** - - -
EQ 4MG BASE/4ML (EQ 1MG BASE/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.